Shenzhen Noposion Crop Science Balance Sheet Health
Financial Health criteria checks 3/6
Shenzhen Noposion Crop Science has a total shareholder equity of CN¥4.1B and total debt of CN¥5.1B, which brings its debt-to-equity ratio to 122.8%. Its total assets and total liabilities are CN¥11.6B and CN¥7.4B respectively. Shenzhen Noposion Crop Science's EBIT is CN¥445.8M making its interest coverage ratio 15.3. It has cash and short-term investments of CN¥1.4B.
Key information
122.8%
Debt to equity ratio
CN¥5.05b
Debt
| Interest coverage ratio | 15.3x |
| Cash | CN¥1.36b |
| Equity | CN¥4.12b |
| Total liabilities | CN¥7.45b |
| Total assets | CN¥11.56b |
Recent financial health updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Shenzhen Noposion Crop Science (SZSE:002215) Passed With Ease
Oct 26
Even With A 26% Surge, Cautious Investors Are Not Rewarding Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Performance Completely
Sep 24These 4 Measures Indicate That Shenzhen Noposion Crop Science (SZSE:002215) Is Using Debt Extensively
Aug 20With EPS Growth And More, Shenzhen Noposion Crop Science (SZSE:002215) Makes An Interesting Case
Jul 19Estimating The Intrinsic Value Of Shenzhen Noposion Crop Science Co., Ltd. (SZSE:002215)
Apr 02Investors Still Aren't Entirely Convinced By Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Earnings Despite 26% Price Jump
Mar 04Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively
Feb 27Financial Position Analysis
Short Term Liabilities: 002215's short term assets (CN¥4.5B) do not cover its short term liabilities (CN¥5.9B).
Long Term Liabilities: 002215's short term assets (CN¥4.5B) exceed its long term liabilities (CN¥1.5B).
Debt to Equity History and Analysis
Debt Level: 002215's net debt to equity ratio (89.7%) is considered high.
Reducing Debt: 002215's debt to equity ratio has increased from 40.8% to 122.8% over the past 5 years.
Debt Coverage: 002215's debt is well covered by operating cash flow (22.9%).
Interest Coverage: 002215's interest payments on its debt are well covered by EBIT (15.3x coverage).